CNE100001JM9
CNE100001JM9
SICHUAN HEBANG BIOTECHNOLOGY CO
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 7.187.510.833 | 8.547.476.550 | 15.9% |
| Cost of Revenue | 6.359.490.473 | 7.880.674.862 | 19.3% |
| Gross Profit | 828.020.360 | 666.801.688 | 24.2% |
| 562.030.035 | 578.400.806 | 2.8% | |
| Operating Income | 265.990.325 | 88.400.882 | 200.9% |
| Pretax Income | -630.842.405 | -65.683.562 | 860.4% |
| Net Income Common Stockholders | -536.406.669 | 31.464.685 | 1804.8% |
| -- | -- | -- | |
| -- | -- | -- |